This finding could have a significant clinical impact and is in agreement with that of the meta-analysis carried out by Xie et al. who collected data from 17 studies with 11,385 colon cancer patients and observed that KRAS mutation was more frequent in right-sided than left-sided colon cancers [17]. Here, KRAS is linked to malignant colon neoplasm.